XASE · MTNB
-1.60% · $0.0000 · Vol 426.6K
Market closed · last close 4:00 PM ET · price as of 20:00:00 ET
Matinas BioPharma Holdings, Inc.

Matinas BioPharma Holdings, Inc.

PHARMACEUTICAL PREPARATIONS
$0.1604
Card
Relationship Map

Follow $MTNB

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $MTNB by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
MTNB
Matinas BioPharma Holdings, Inc.
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

37/ 100
Veridion Score
Lower range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is MTNB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading MTNB catalysts
About Matinas BioPharma Holdings, Inc.
PHARMACEUTICAL PREPARATIONS
Listed since
2014
Employees
2
Country
US

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.1633
Day high
$0.1690
Day low
$0.1580
Previous close
$0.1630
52W high
$2.06
-92.21% from high
52W low
$0.1580
0% of range
Market cap
$2.4M
EPS
$-1.9400
Beta
1.18
Shares out
14.7M
Volume
426.6K
0.35× rel vol
Avg volume
1.2M
VWAP
$0.1612
Price history computed in-house
1W
-13.30%
1M
-19.32%
3M
-74.58%
1Y
-90.83%
YTD
-72.63%
SMA 50 $0.2550 · below
SMA 200 $0.5501 · below
52W position 0%

MTNB overview

Veridion Score
37
Registered · 2026-09-18
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around MTNB.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading MTNB Form 4 filings
Public disclosures

Congress activity in MTNB

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for MTNB in the cached public ledger.

Federal contracts

MTNB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MTNB in this window.
Lobbying spend

MTNB lobbying filings, year to date.

Registered lobbying filings matched to Matinas BioPharma Holdings, Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MTNB in this window.
Loading news for MTNB
Analyst ratings
Sovereign unlock shows live analyst consensus for MTNB.
Options
Sovereign unlock shows live options positioning for MTNB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.